Literature DB >> 17264902

Rhodium-catalysed substitutive arylation of cis-allylic diols with arylboroxines.

Tomoya Miura1, Yusuke Takahashi, Masahiro Murakami.   

Abstract

Substitutive arylation of cis-allylic diols occurs upon treatment with arylboroxines in the presence of a rhodium(I) catalyst; the reaction proceeds through the addition of an intermediate arylrhodium(I) species across the carbon-carbon double bond and subsequent beta-oxygen elimination.

Entities:  

Year:  2006        PMID: 17264902     DOI: 10.1039/b612710j

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

Review 1.  Enantioselective and Enantiospecific Transition-Metal-Catalyzed Cross-Coupling Reactions of Organometallic Reagents To Construct C-C Bonds.

Authors:  Alan H Cherney; Nathaniel T Kadunce; Sarah E Reisman
Journal:  Chem Rev       Date:  2015-08-13       Impact factor: 60.622

2.  Simple chiral diene ligands provide high enantioselectivities in transition-metal-catalyzed conjugate addition reactions.

Authors:  Kazuhiro Okamoto; Tamio Hayashi; Viresh H Rawal
Journal:  Org Lett       Date:  2008-09-05       Impact factor: 6.005

3.  Enantiospecific, nickel-catalyzed cross-couplings of allylic pivalates and arylboroxines.

Authors:  Harathi D Srinivas; Qi Zhou; Mary P Watson
Journal:  Org Lett       Date:  2014-06-13       Impact factor: 6.005

4.  Asymmetric Suzuki-Miyaura coupling of heterocycles via Rhodium-catalysed allylic arylation of racemates.

Authors:  Philipp Schäfer; Thomas Palacin; Mireia Sidera; Stephen P Fletcher
Journal:  Nat Commun       Date:  2017-06-13       Impact factor: 14.919

5.  Desymmetrization of meso-Dibromocycloalkenes through Copper(I)-Catalyzed Asymmetric Allylic Substitution with Organolithium Reagents.

Authors:  Shermin S Goh; Sureshbabu Guduguntla; Takashi Kikuchi; Martin Lutz; Edwin Otten; Makoto Fujita; Ben L Feringa
Journal:  J Am Chem Soc       Date:  2018-05-31       Impact factor: 15.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.